{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:06:57Z","timestamp":1791256017924,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BBS\/E\/I\/00007038"],"award-info":[{"award-number":["BBS\/E\/I\/00007038"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BBS\/E\/I\/00007039"],"award-info":[{"award-number":["BBS\/E\/I\/00007039"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BBS\/E\/I\/00007031"],"award-info":[{"award-number":["BBS\/E\/I\/00007031"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.vaccine.2025.127360","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T05:01:14Z","timestamp":1750395674000},"page":"127360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["IFITM knockout DF1 cells produce higher influenza and newcastle disease viral yields: a proof of concept for avian origin cell-based vaccine production"],"prefix":"10.1016","volume":"61","author":[{"given":"Ahmed","family":"Samy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Alber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Fife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2025.127360_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.xinn.2022.100357","article-title":"Synthetic microbiome for a sustainable poultry industry","volume":"4","author":"Hu","year":"2023","journal-title":"The Innovation"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127360_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.biologicals.2015.09.002","article-title":"Development, characterization and optimization of a new suspension chicken-induced pluripotent cell line for the production of Newcastle disease vaccine","volume":"44","author":"Shittu","year":"2016","journal-title":"Biologicals"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127360_bb0015","article-title":"Drivers for a pandemic due to avian influenza and options for one health mitigation measures","volume":"22","author":"Adlhoch","year":"2024","journal-title":"EFSA J"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127360_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/v14061195","article-title":"Vaccines against major poultry viral diseases: strategies to improve the breadth and protective efficacy","volume":"14","author":"Ravikumar","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127360_bb0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/03079457.2016.1138280","article-title":"Continuous cell lines from the Muscovy duck as potential replacement for primary cells in the production of avian vaccines","volume":"45","author":"Jordan","year":"2016","journal-title":"Avian Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127360_bb0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.puhe.2007.06.005","article-title":"A systematic analysis of influenza vaccine shortage policies","volume":"122","author":"Uscher-Pines","year":"2008","journal-title":"Public Health"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127360_bb0035","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1080\/21645515.2015.1016666","article-title":"Cell culture-based influenza vaccines: a necessary and indispensable investment for the future","volume":"11","author":"Hegde","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127360_bb0040","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.vaccine.2008.11.066","article-title":"An avian cell line designed for production of highly attenuated viruses","volume":"27","author":"Jordan","year":"2009","journal-title":"Vaccine"},{"issue":"47","key":"10.1016\/j.vaccine.2025.127360_bb0045","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1016\/j.vaccine.2019.06.005","article-title":"Influenza a virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems","volume":"37","author":"Coronel","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127360_bb0050","doi-asserted-by":"crossref","first-page":"2373521","DOI":"10.1080\/21645515.2024.2373521","article-title":"Innovations in cell culture-based influenza vaccine manufacturing \u2013 from static cultures to high cell density cultivations","volume":"20","author":"Zinnecker","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127360_bb0055","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/biot.201400387","article-title":"Viral vaccines and their manufacturing cell substrates: new trends and designs in modern vaccinology","volume":"10","author":"Rodrigues","year":"2015","journal-title":"Biotechnol J"},{"issue":"Pt 7","key":"10.1016\/j.vaccine.2025.127360_bb0060","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1099\/vir.0.020370-0","article-title":"High yields of influenza a virus in Madin-Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state","volume":"91","author":"Seitz","year":"2010","journal-title":"J Gen Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127360_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059307","article-title":"The differential antiviral activities of chicken interferon \u03b1 (ChIFN-\u03b1) and ChIFN-\u03b2 are related to distinct interferon-stimulated gene expression","volume":"8","author":"Qu","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127360_bb0070","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1128\/JVI.01464-15","article-title":"Engineering enhanced vaccine cell lines to eradicate vaccine-preventable diseases: the polio end game","volume":"90","author":"van der Sanden","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127360_bb0075","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.3389\/fmicb.2018.03228","article-title":"IFITM genes, variants, and their roles in the control and pathogenesis of viral infections","volume":"9","author":"Zhao","year":"2018","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127360_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007532","article-title":"Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes","volume":"15","author":"Suddala","year":"2019","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127360_bb0085","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200303","article-title":"IFITM3 incorporation sensitizes influenza a virus to antibody-mediated neutralization","volume":"218","author":"Lanz","year":"2021","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127360_bb0090","doi-asserted-by":"crossref","first-page":"e02003","DOI":"10.1128\/JVI.02003-18","article-title":"Interferon-induced transmembrane protein 1 restricts replication of viruses that enter cells via the plasma membrane","volume":"93","author":"Smith","year":"2019","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.vaccine.2025.127360_bb0095","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1016\/j.jmb.2013.09.024","article-title":"IFITMs restrict the replication of multiple pathogenic viruses","volume":"425","author":"Perreira","year":"2013","journal-title":"J Mol Biol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127360_bb0100","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","article-title":"The IFITM proteins mediate cellular resistance to influenza a H1N1 virus, West Nile virus, and dengue virus","volume":"139","author":"Brass","year":"2009","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127360_bb0105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41589-018-0213-2","article-title":"IFITM3 directly engages and shuttles incoming virus particles to lysosomes","volume":"15","author":"Spence","year":"2019","journal-title":"Nat Chem Biol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127360_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004048","article-title":"IFITM3 restricts influenza a virus entry by blocking the formation of fusion pores following virus-endosome hemifusion","volume":"10","author":"Desai","year":"2014","journal-title":"PLoS Pathog"},{"issue":"23","key":"10.1016\/j.vaccine.2025.127360_bb0115","doi-asserted-by":"crossref","first-page":"12957","DOI":"10.1128\/JVI.01443-13","article-title":"Chicken interferon-inducible transmembrane protein 3 restricts influenza viruses and lyssaviruses in vitro","volume":"87","author":"Smith","year":"2013","journal-title":"J Virol"},{"issue":"13","key":"10.1016\/j.vaccine.2025.127360_bb0120","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02288-20","article-title":"Newcastle disease virus entry into chicken macrophages via a pH-dependent, dynamin and Caveola-mediated endocytic pathway that requires Rab5","volume":"95","author":"Zhao","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127360_bb0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-virology-031413-085537","article-title":"IFITM-family proteins: the cell\u2019s first line of antiviral defense","volume":"1","author":"Bailey","year":"2014","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.vaccine.2025.127360_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2022.109597","article-title":"Chicken interferon-induced transmembrane protein 1 promotes replication of coronavirus infectious bronchitis virus in a cell-specific manner","volume":"275","author":"Li","year":"2022","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127360_bb0135","doi-asserted-by":"crossref","first-page":"2172965","DOI":"10.1080\/22221751.2023.2172965","article-title":"Risk assessment of the newly emerged H7N9 avian influenza viruses","volume":"12","author":"Chang","year":"2023","journal-title":"Emerging Microbes & Infections"},{"key":"10.1016\/j.vaccine.2025.127360_bb0140","series-title":"Molecular mechanisms of oncolytic properties of Newcastle disease virus (NDV) in human cancer cells","author":"Jadhav","year":"2020"},{"key":"10.1016\/j.vaccine.2025.127360_bb0145","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2015.37","article-title":"Off-target effects in CRISPR\/Cas9-mediated genome engineering","volume":"4","author":"Zhang","year":"2015","journal-title":"Molecular Therapy - Nucleic Acids"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127360_bb0150","doi-asserted-by":"crossref","first-page":"18211","DOI":"10.1038\/s41598-022-22885-8","article-title":"Wildtype heterogeneity contributes to clonal variability in genome edited cells","volume":"12","author":"Westermann","year":"2022","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127360_bb0155","doi-asserted-by":"crossref","first-page":"8841","DOI":"10.1002\/jcb.27137","article-title":"The establishment of clonally derived chicken embryonic fibroblast cell line (CSC) with high transfection efficiency and ability as a feeder cell","volume":"119","author":"Zhao","year":"2018","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.vaccine.2025.127360_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.936251","article-title":"Review detection of Newcastle disease virus","volume":"9","author":"Mao","year":"2022","journal-title":"Front Vet Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127360_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006276","article-title":"H1N1 influenza viruses varying widely in hemagglutinin stability transmit efficiently from swine to swine and to ferrets","volume":"13","author":"Russier","year":"2017","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127360_bb0170","doi-asserted-by":"crossref","first-page":"18008","DOI":"10.1038\/s41598-020-74604-w","article-title":"Cell-penetrating peptide-mediated cell entry of H5N1 highly pathogenic avian influenza virus","volume":"10","author":"Kajiwara","year":"2020","journal-title":"Sci Rep"},{"issue":"1 Suppl","key":"10.1016\/j.vaccine.2025.127360_bb0175","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1637\/8837-040309-Reg.1","article-title":"Evaluation and attempted optimization of avian embryos and cell culture methods for efficient isolation and propagation of low pathogenicity avian influenza viruses","volume":"54","author":"Moresco","year":"2010","journal-title":"Avian Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127360_bb0180","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/viro.1998.9290","article-title":"The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian Leukosis viruses","volume":"248","author":"Himly","year":"1998","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127360_bb0185","doi-asserted-by":"crossref","first-page":"17485","DOI":"10.1038\/s41598-017-17730-2","article-title":"Constitutively elevated levels of SOCS1 suppress innate responses in DF-1 immortalised chicken fibroblast cells","volume":"7","author":"Giotis","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127360_bb0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1128\/JVI.01593-15","article-title":"Duck interferon-inducible transmembrane protein 3 mediates restriction of influenza viruses","volume":"90","author":"Blyth","year":"2016","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.vaccine.2025.127360_bb0195","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00837-21","article-title":"IFITM proteins that restrict the early stages of respiratory virus infection do not influence late-stage replication","volume":"95","author":"Meischel","year":"2021","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127360_bb0200","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3390\/pathogens12040519","article-title":"Caveats of using overexpression approaches to screen cellular host IFITM proteins for antiviral activity","volume":"12","author":"Meischel","year":"2023","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127360_bb0205","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201900542","article-title":"Bat IFITM3 restriction depends on S-palmitoylation and a polymorphic site within the CD225 domain","volume":"3","author":"Benfield","year":"2020","journal-title":"Life Science Alliance"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127360_bb0210","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1099\/0022-1317-16-1-95","article-title":"Cell fusion by Newcastle disease virus","volume":"16","author":"Poste","year":"1972","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127360_bb0215","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03088-19","article-title":"IFITM3 reduces retroviral envelope abundance and function and is counteracted by glycoGag","volume":"11","author":"Ahi","year":"2020","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127360_bb0220","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01716-18","article-title":"Functional mapping of regions involved in the negative imprinting of Virion particle infectivity and in target cell protection by interferon-induced transmembrane protein 3 against HIV-1","volume":"93","author":"Appourchaux","year":"2019","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127360_bb0225","doi-asserted-by":"crossref","first-page":"23328","DOI":"10.1038\/srep23328","article-title":"Single-cell lineage tracking analysis reveals that an established cell line comprises putative cancer stem cells and their heterogeneous progeny","volume":"6","author":"Sato","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127360_bb0230","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/biot.201400388","article-title":"Designing cell lines for viral vaccine production: where do we stand?","volume":"10","author":"Genzel","year":"2015","journal-title":"Biotechnol J"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127360_bb0235","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/pr5020020","article-title":"Cloning of CHO cells, productivity and genetic stability\u2014a discussion","volume":"5","author":"Wurm","year":"2017","journal-title":"Processes"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127360_bb0240","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.biologicals.2016.01.001","article-title":"Industry view on the relative importance of \u201cclonality\u201d of biopharmaceutical-producing cell lines","volume":"44","author":"Frye","year":"2016","journal-title":"Biologicals"},{"issue":"24","key":"10.1016\/j.vaccine.2025.127360_bb0245","doi-asserted-by":"crossref","first-page":"17261","DOI":"10.1074\/jbc.M112.438515","article-title":"Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry","volume":"288","author":"Anafu","year":"2013","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127360_bb0250","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/03079457.2017.1393044","article-title":"Propagation and titration of infectious bursal disease virus, including non-cell-culture-adapted strains, using ex vivo-stimulated chicken bursal cells","volume":"47","author":"Soubies","year":"2018","journal-title":"Avian Pathol"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127360_bb0255","doi-asserted-by":"crossref","first-page":"e02402","DOI":"10.1128\/spectrum.02402-23","article-title":"Differential analysis of IBV-infected primary chicken embryonic fibroblasts and immortalized DF-1","volume":"12","author":"Yang","year":"2024","journal-title":"Microbiol Spectrum"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127360_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/genes11080918","article-title":"The characterization of chIFITMs in avian coronavirus infection in vivo, ex vivo and in vitro","volume":"11","author":"Steyn","year":"2020","journal-title":"Genes (Basel)"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127360_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160173","article-title":"A versatile panel of reference gene assays for the measurement of chicken mRNA by quantitative PCR","volume":"11","author":"Staines","year":"2016","journal-title":"PLoS One"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25006577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25006577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T17:43:38Z","timestamp":1762278218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25006577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":53,"alternative-id":["S0264410X25006577"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127360","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IFITM knockout DF1 cells produce higher influenza and newcastle disease viral yields: a proof of concept for avian origin cell-based vaccine production","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127360"}}